Skip to main content

Abstract

Uterine myomas or fibroids are the most common benign tumors of the genital organs of women, with a frequent negative impact on reproductive system. They can be single or multiple, and frequently cause of significant female morbidity for interference on the of quality of life [1]. Literature data show that 5.4–77 % of women have myomas, depending either on the study population or by diagnostic techniques applied to myoma detecting [2]. The myoma prevalence is somewhat lower in Europe than in the United States, which are more influenced by racial differences [3]. They are detected in 70 % of uteri after hysterectomy (more than 80 % of cases in the form of multiple myomas) [4]. On 100 total hysterectomy, specimens performed at a distance of 2 mm demonstrated myomas in 73 % of samples of the uterus in premenopausal women and 84 % of the uterus in postmenopausal women. The average number of myomas in this study was 7.6 % among premenopausal women and 4.2 % in postmenopausal women [4]. Previous epidemiological studies, focusing mostly on symptomatic women, largely underestimated myoma prevalence. Fibroids consist mainly of smooth muscle cells (Fig. 6.1) with different amounts of fibrous tissue so, generally, they are benign with few symptoms, but when they disrupt the uterine functions, they cause: excessive uterine bleeding, anemia, defective implantation of an embryo, recurrent pregnancy loss, preterm labor, obstruction of labor, pelvic discomfort, and urinary incontinence and may mimic or mask malignant tumors [5]. Larger fibroids (Fig. 6.2) can even compress any of the surrounding organs, leading to urinary, digestive or sexual symptoms [6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–55.

    Article  CAS  PubMed  Google Scholar 

  2. Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician. 2007;75(10):1503–8.

    PubMed  Google Scholar 

  3. Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update. 2007;13(5):465–76.

    Article  CAS  PubMed  Google Scholar 

  4. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–8.

    CAS  PubMed  Google Scholar 

  5. Catherino WH, Parrott E, Segars J. Proceedings from the National Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop. Fertil Steril. 2011;95:9–12.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Womens Health. 2014;6:95–114.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Falcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol. 2013;121(4):856–68. doi:10.1097/AOG.0b013e3182888478.

    Article  PubMed  Google Scholar 

  8. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Clin Evid. 2011;2011. pii: 0814.

    Google Scholar 

  9. Stovall DW. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Menopause. 2011;18(4):443–50.

    Article  Google Scholar 

  10. Tinelli A, Malvasi A, Rahimi S, Negro R, Cavallotti C, Vergara D, Vittori G, Mettler L. Myoma pseudocapsule: a distinct endocrino-anatomical entity in gynecological surgery. Gynecol Endocrinol. 2009;25(10):661–7.

    Article  PubMed  Google Scholar 

  11. Tinelli A, Malvasi A, Guido M, Tsin DA, Hudelist G, Hurst B, Stark M, Mettler L. Adhesion formation after intracapsular myomectomy with or without adhesion barrier. Fertil Steril. 2011;95(5):1780–5.

    Article  PubMed  Google Scholar 

  12. Tinelli A, Malvasi A, Cavallotti C, Dell’Edera D, Tsin DA, Stark M, Mettler L. The management of fibroids based on immunohistochemical studies of their pseudocapsules. Expert Opin Ther Targets. 2011;15(11):1241–7.

    Article  CAS  PubMed  Google Scholar 

  13. Pasetto N, Baschieri L, Giacomello F, Ticconi C. Patologia benigna dell’utero. In: Candiani GB, Danesino V, Gastaldi C, editors. La clinica ostetrica e ginecologica. Milan: Masson Editore; 1992. p. 1242–56.

    Google Scholar 

  14. Hurst BS. Uterine fibroids, chapter 10. In: Stadtmauer LA, Tur-Kaspa I, editors. Ultrasound imaging in reproductive medicine. New York: Springer; 2014. p. 117–31.

    Chapter  Google Scholar 

  15. Faulkner RL. The blood vessels of the myomatous uteri. Am J Obstet Gynecol. 1944;47:185–97.

    Google Scholar 

  16. Farrer-Brown G, Beilby JOW, Tarbit MH. The vascular patterns in myomatous uteri. J Obstet Gynaecol. 1970;77:967–75.

    Article  CAS  Google Scholar 

  17. Awataguchi K. Studies on the angioarchitecture of uterine myoma. Nippon Ika Daigaku Zasshi. 1982;49:225–32.

    CAS  PubMed  Google Scholar 

  18. Casey R, Rogers PA, Vollenhoven BJ. An immunohistochemical analysis of fibroid vasculature. Hum Reprod. 2000;15(7):1469–75.

    Article  CAS  PubMed  Google Scholar 

  19. Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod. 1999;14:44–8.

    Article  CAS  PubMed  Google Scholar 

  20. Lethaby A, Vollenhoven B, Sowter M. Pre-operative Gn-RH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;(2):CD000547.

    Google Scholar 

  21. Pinkerton JV. Pharmacological therapy for abnormal uterine bleeding. Menopause. 2011;18(4):459–67.

    Article  Google Scholar 

  22. Walocha JA, Litwin JA, Miodonski A. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy. Hum Reprod. 2003;18:1088–93.

    Article  PubMed  Google Scholar 

  23. Forssman L. Blood flow in myomatous uteri as measured by intraarterial 133-Xenon. Acta Obstet Gynecol Scand. 1976;55:21–4.

    Article  CAS  PubMed  Google Scholar 

  24. Malvasi A, Cavallotti C, Morroni M, Lorenzi T, Dell’Edera D, Nicolardi G, Tinelli A. Uterine fibroid pseudocapsule studied by transmission electron microscopy. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):187–91.

    Article  PubMed  Google Scholar 

  25. Wei JJ, Zhang XM, Chiriboga L, Yee H, Perle MA, Mittal K. Spatial differences in biologic activity of large uterine leiomyomata. Fertil Steril. 2006;85:179–87.

    Article  CAS  PubMed  Google Scholar 

  26. Mettler L, Tinelli A, Hurst BS, Teigland CM, Sammur W, Dell’Edera D, Negro R, Gustapane S, Malvasi A. Neurovascular bundle in fibroid pseudocapsule and its neuroendocrinologic implications. Expert Rev Endocrinol Metab. 2011;6(5):715–22.

    Article  Google Scholar 

  27. Malvasi A, Tinelli A, Cavallotti C, Morroni M, Tsin DA, Nezhat C, et al. Distribution of substance P (SP) and vasoactive intestinal peptide (VIP) in pseudocapsules of uterine fibroids. Peptides. 2011;32:327–32.

    Article  CAS  PubMed  Google Scholar 

  28. Malvasi A, Cavallotti C, Nicolardi G, Pellegrino M, Dell’edera D, Vergara D, et al. NT, NPY and PGP 9.5 presence in myometrium and in fibroid pseudocapsule and their possible impact on muscular physiology. Gynecol Endocrinol. 2013;29:177–81.

    Article  PubMed  Google Scholar 

  29. Malvasi A, Cavallotti C, Nicolardi G, Pellegrino M, Vergara D, Greco M, et al. The opioid neuropeptides in uterine fibroid pseudocapsules: a putative association with cervical integrity in human reproduction. Gynecol Endocrinol. 2013;29:982–8.

    Article  CAS  PubMed  Google Scholar 

  30. Tinelli A, Hurst BS, Mettler L, Tsin DA, Pellegrino M, Nicolardi G, et al. Ultrasound evaluation of uterine healing after laparoscopic intracapsular myomectomy: an observational study. Hum Reprod. 2012;27:2664–70.

    Article  PubMed  Google Scholar 

  31. Delgado AV, McManus AT, Chambers JP. Exogenous administration of Substance P enhances wound healing in a novel skin-injury model. Exp Biol Med (Maywood). 2005;230:271–80.

    CAS  Google Scholar 

  32. Jiang MH, Chung E, Chi GF, Ahn W, Lim JE, Hong HS, et al. Substance P induces M2-type macrophages after spinal cord injury. Neuroreport. 2012;23:786–92.

    Article  CAS  PubMed  Google Scholar 

  33. Malvasi A, Tinelli A, Cavallotti C, Bettocchi S, Di Renzo GC, Stark M. Substance P (SP) and vasoactive intestinal polypeptide (VIP) in the lower uterine segment in first and repeated cesarean sections. Peptides. 2010;31:2052–9.

    Article  CAS  PubMed  Google Scholar 

  34. Collins JJ, Usip S, McCarson KE, Papka RE. Sensory nerves and neuropeptides in uterine cervical ripening. Peptides. 2002;23:167–83.

    Article  CAS  PubMed  Google Scholar 

  35. Tingaker BK, Ekman-Ordeberg G, Facer P, Irestedt L, Anand P. Influence of pregnancy and labor on the occurrence of nerve fibers expressing the capsaicin receptor TRPV1 in human corpus and cervix uteri. Reprod Biol Endocrinol. 2008;6:8.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Tingaker BK, Ekman-Ordeberg G, Forsgren S. Presence of sensory nerve corpuscles in the human corpus and cervix uteri during pregnancy and labor as revealed by immunohistochemistry. Reprod Biol Endocrinol. 2006;4:45.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Cormio L, Gesualdo L, Maiorano E, Bettocchi C, Palumbo F, Traficante A, et al. Vasoactive intestinal polypeptide (VIP) is not an androgen-dependent neuromediator of penile erection. Int J Impot Res. 2005;17:23–6.

    Article  CAS  PubMed  Google Scholar 

  38. Rodríguez R, Pozuelo JM, Martín R, Arriazu R, Santamaria L. Stereological quantification of nerve fibers immunoreactive to PGP 9.5, NPY, and VIP in rat prostate during postnatal development. J Androl. 2005;26:197–204.

    PubMed  Google Scholar 

  39. Arms L, Vizzard MA. Neuropeptides in lower urinary tract function. Handb Exp Pharmacol. 2011;202:395–423.

    Article  CAS  PubMed  Google Scholar 

  40. Merrill L, Girard B, Arms L, Guertin P, Vizzard MA. Neuropeptide/receptor expression and plasticity in micturition pathways. Curr Pharm Des. 2013;19:4411–22.

    Article  CAS  PubMed  Google Scholar 

  41. Yucel S, Erdogru T, Baykara M. Recent neuroanatomical studies on the neurovascular bundle of the prostate and cavernosal nerves: clinical reflections on radical prostatectomy. Asian J Androl. 2005;7(4):339–49.

    Article  PubMed  Google Scholar 

  42. Takenaka A, Murakami G, Soga H, Han SH, Arai Y, Fujisawa M. Anatomical analysis of the neurovascular bundle supplying penile cavernous tissue to ensure a reliable nerve graft after radical prostatectomy. J Urol. 2004;172(3):1032–5.

    Article  PubMed  Google Scholar 

  43. Costello AJ, Brooks M, Cole OJ. Anatomical studies of the neurovascular bundle and cavernosal nerves. BJU Int. 2004;94(7):1071–6.

    Article  PubMed  Google Scholar 

  44. Walsh PC. The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol. 2007;177(5):1632–5.

    Article  PubMed  Google Scholar 

  45. Hernandez DJ, Epstein JI, Trock BJ, Tsuzuki T, Carter HB, Walsh PC. Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle? J Urol. 2005;173(2):446–9.

    Article  PubMed  Google Scholar 

  46. Shah SJ, Goyal V, Sachar R, Nath AK, Jain N, Kapadia K. Seminal vesicle sparing laparoscopic radical prostatectomy using a low-energy source: better continence and potency. Indian J Urol. 2009;25(2):199–202.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Han M, Kim C, Mozer P, Schäfer F, Badaan S, Vigaru B, Tseng K, Petrisor D, Trock B, Stoianovici D. Tandem-robot assisted laparoscopic radical prostatectomy to improve the neurovascular bundle visualization: a feasibility study. Urology. 2011;77(2):502–6.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, Menon M, Montorsi F, Myers RP, Rocco B, Villers A. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol. 2010;57(2):179–92.

    Article  PubMed  Google Scholar 

  49. Lee SE, Hong SK, Han JH, Han BK, Yu JH, Jeong SJ, Byun SS, Lee HJ. Significance of neurovascular bundle formation observed on preoperative magnetic resonance imaging regarding postoperative erectile function after nerve-sparing radical retropubic prostatectomy. Urology. 2007;69(3):510–4.

    Article  PubMed  Google Scholar 

  50. Ong AM, Su LM, Varkarakis I, Inagaki T, Link RE, Bhayani SB, Patriciu A, Crain B, Walsh PC. Nerve sparing radical prostatectomy: effects of hemostatic energy sources on the recovery of cavernous nerve function in a canine model. J Urol. 2004;172(4 Pt 1):1318–22.

    Article  PubMed  Google Scholar 

  51. Ukimura O, Gill IS. Real-time transrectal ultrasound guidance during nerve sparing laparoscopic radical prostatectomy: pictorial essay. J Urol. 2006;175(4):1311–9.

    Article  PubMed  Google Scholar 

  52. Tinelli A, Malvasi A, Hudelist G, Cavallotti C, Tsin DA, Schollmeyer T, Bojahr B, Mettler L. Laparoscopic intracapsular myomectomy: comparison of single versus multiple fibroids removal. An institutional experience. J Laparoendosc Adv Surg Tech A. 2010;20(8):705–11.

    Article  PubMed  Google Scholar 

  53. Tinelli A, Hurst BS, Hudelist G, Tsin DA, Stark M, Mettler L, Guido M, Malvasi A. Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports. Hum Reprod. 2012;27(2):427–35.

    Article  PubMed  Google Scholar 

  54. Ito F, Kawamura N, Ichimura T, Tsujimura A, Ishiko O, Ogita S. Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment. Fertil Steril. 2001;75:l25–130.

    Google Scholar 

  55. Dapunt O. Studies on the structure of the myoma capsule. Arch Gynecol. 1965;202:492–4.

    Article  CAS  Google Scholar 

  56. Fox H, Buckley CH. Benign neoplasms of the female genital tract. In: Pathology for gynaecologists, vol. 8. London: Arnold Ed; 1982. p. 91–7.

    Google Scholar 

  57. Vizza E, Motta PM. The skeleton fibrous and muscolar of the uterus. In: Atti LXXVII Congresso SIGO. Rome: CIC Int Ed; 2001. p. 47–9.

    Google Scholar 

  58. Hsu WC, Hwang JS, Chang WC, Huang SC, Sheu BC, Torng PL. Prediction of operation time for laparoscopic myomectomy by ultrasound measurements. Surg Endosc. 2007;21(9):1600–6.

    Article  PubMed  Google Scholar 

  59. Tinelli A, Mettler L, Malvasi A, Hurst B, Catherino W, Mynbaev OA, Guido M, Alkatout I, Schollmeyer T. Impact of surgical approach on blood loss during intracapsular myomectomy. Minim Invasive Ther Allied Technol. 2014;23(2):87–95.

    Article  PubMed  Google Scholar 

  60. Di Tommaso S, Massari S, Malvasi A, Bozzetti MP, Tinelli A. Gene expression analysis reveals an angiogenic profile in uterine leiomyoma pseudocapsule. Mol Hum Reprod. 2013;19(6):380–7.

    Article  PubMed  Google Scholar 

  61. Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update. 1996;2(4):295–306.

    Article  CAS  PubMed  Google Scholar 

  62. Hanna KR, Katz AJ. An update on wound healing and the nervous system. Ann Plast Surg. 2011;67(1):49–52.

    Article  CAS  PubMed  Google Scholar 

  63. Henderson J, Terenghi G, Ferguson MW. The reinnervation and revascularisation pattern of scarless murine fetal wounds. J Anat. 2011;218(6):660–7.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Gouin JP, Carter CS, Pournajafi-Nazarloo H, Glaser R, Malarkey WB, Loving TJ, Stowell J, Kiecolt-Glaser JK. Marital behavior, oxytocin, vasopressin, and wound healing. Psychoneuroendocrinology. 2010;35(7):1082–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  65. Malvasi A, Tinelli A, Rahimi S, D’Agnese G, Rotoni C, Dell’edera D, Tsin DA, Cavallotti C. A three-dimensional morphological reconstruction of uterine leiomyoma pseudocapsule vasculature by the Allen-Cahn mathematical model. Biomed Pharmacother. 2011;65(5):359–63.

    Article  PubMed  Google Scholar 

  66. Vikhareva Osser O, Valentin L. Risk factors for incomplete healing of the uterine incision after caesarean section. BJOG. 2010;117(9):1119–26.

    Article  CAS  PubMed  Google Scholar 

  67. Kubinova K, Mara M, Horak P, Kuzel D, Dohnalova A. Reproduction after myomectomy: comparison of patients with and without second-look laparoscopy. Minim Invasive Ther Allied Technol. 2012;21(2):118–24.

    Article  PubMed  Google Scholar 

  68. Quinn MJ, Kirk N. Differences in uterine innervation at hysterectomy. Am J Obstet Gynecol. 2002;187(6):1515–20.

    Article  PubMed  Google Scholar 

  69. Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA. Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU Int. 2008;101(10):1217–22.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Hurst BS, Matthews ML, Marshburn PB. Laparoscopic myomectomy for symptomatic uterine myomas. Fertil Steril. 2005;83(1):1–23.

    Article  PubMed  Google Scholar 

  71. Tinelli A, Malvasi A, Hurst BS, Tsin DA, Davila F, Dominguez G, Dell’Edera D, Cavallotti C, Negro R, Gustapane S, Teigland CM, Mettler L. Surgical management of neurovascular bundle in uterine fibroids pseudocapsule. JSLS. 2012;16:119–29.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Tinelli A, Mynbaev OA, Mettler L, Hurst BS, Pellegrino M, Nicolardi G, Kosmas I, Malvasi A. A combined ultrasound and histologic approach for analysis of uterine fibroid pseudocapsule thickness. Reprod Sci. 2014;21:1177–86. pii:1933719114537719.

    Article  PubMed  Google Scholar 

  73. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91(4):1215–23.

    Article  PubMed  Google Scholar 

  74. Shavell VI, Thakur M, Sawant A, Kruger ML, Jones TB, Singh M, Puscheck EE, Diamond MP. Adverse obstetric outcomes associated with sonographically identified large uterine fibroids. Fertil Steril. 2012;97(1):107–10.

    Article  PubMed  Google Scholar 

  75. Ikechebelu JI, Ezeama CO, Obiechina NJ. The use of torniquet to reduce blood loss at myomectomy. Niger J Clin Pract. 2010;13(2):154–8.

    CAS  PubMed  Google Scholar 

  76. Al-Shabibi N, Chapman L, Madari S, Papadimitriou A, Papalampros P, Magos A. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy. BJOG. 2009;116(5):681–7.

    Article  CAS  PubMed  Google Scholar 

  77. Firouznia K, Ghanaati H, Jalali AH, Shakiba M. Uterine artery embolization for treatment of symptomatic fibroids: a review of the evidence. Iran Red Crescent Med J. 2013;15(12):e16699.

    Article  PubMed Central  PubMed  Google Scholar 

  78. Chang WC, Chou LY, Chang DY, Huang PS, Huang SC, Chen SY, Sheu BC. Simultaneous laparoscopic uterine artery ligation and laparoscopic myomectomy for symptomatic uterine myomas with and without in situ morcellation. Hum Reprod. 2011;26(7):1735–40.

    Article  PubMed  Google Scholar 

  79. Riess ML, Ulrichs JG, Pagel PS, Woehlck HJ. Severe vasospasm mimics hypotension after high-dose intrauterine vasopressin. Anesth Analg. 2011;113(5):1103–5.

    Article  PubMed  Google Scholar 

  80. Frishman GN, Jurema MW. Myomas and myomectomy. J Minim Invasive Gynecol. 2005;12:443–56.

    Article  PubMed  Google Scholar 

  81. Chen I, Motan T, Kiddoo D. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol. 2011;18(3):303–9.

    Article  PubMed  Google Scholar 

  82. Al-Talib A. Factors contributing to failure of laparoscopic myomectomy. Surg Technol Int. 2013;23:149–51.

    PubMed  Google Scholar 

  83. Chang WC, Chang DY, Huang SC, Shih JC, Hsu WC, Chen SY, Sheu BC. Use of three-dimensional ultrasonography in the evaluation of uterine perfusion and healing after laparoscopic myomectomy. Fertil Steril. 2009;92(3):1110–5.

    Article  PubMed  Google Scholar 

  84. Frederick S, Frederick J, Fletcher H, Reid M, Hardie M, Gardner W. A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy. Fertil Steril. 2013;100(4):1044–9.

    Article  CAS  PubMed  Google Scholar 

  85. Sankaran S, Manyonda IT. Medical management of fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):655–76.

    Article  PubMed  Google Scholar 

  86. De Falco M, Staibano S, Mascolo M, Mignogna C, Improda L, Ciociola F, Carbone IF, Di Lieto A. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes. Eur J Obstet Gynecol Reprod Biol. 2009;144(1):44–7.

    Article  PubMed  Google Scholar 

  87. Malvasi A, Tinelli A, Farine D, Rahimi S, Cavallotti C, Vergara D, Martignago R, Stark M. Effects of visceral peritoneal closure on scar formation at cesarean delivery. Int J Gynaecol Obstet. 2009;105(2):131–5.

    Article  PubMed  Google Scholar 

Download references

Disclosure of Interest

Authors certify that there is no actual or potential conflict of interest in relation to this article and they reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated – including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Tinelli MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Tinelli, A., Malvasi, A. (2015). Uterine Fibroid Pseudocapsule. In: Tinelli, A., Malvasi, A. (eds) Uterine Myoma, Myomectomy and Minimally Invasive Treatments. Springer, Cham. https://doi.org/10.1007/978-3-319-10305-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-10305-1_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-10304-4

  • Online ISBN: 978-3-319-10305-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics